Positive News SentimentPositive NewsNASDAQ:APYX Apyx Medical (APYX) Stock Price, News & Analysis → The Single Biggest Breakthrough of the Decade (From Porter & Company) (Ad) Free APYX Stock Alerts $1.46 -0.09 (-5.81%) (As of 06/13/2024 ET) Add Compare Share Share Today's Range$1.46▼$1.5150-Day Range$1.26▼$1.6652-Week Range$1.21▼$7.97Volume16,247 shsAverage Volume122,305 shsMarket Capitalization$50.57 millionP/E RatioN/ADividend YieldN/APrice Target$6.17 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Apyx Medical alerts: Email Address Apyx Medical MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside322.4% Upside$6.17 Price TargetShort InterestHealthy1.15% of Float Sold ShortDividend StrengthN/ASustainability-1.07Upright™ Environmental ScoreNews Sentiment1.51Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.75) to ($0.60) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.49 out of 5 starsMedical Sector87th out of 917 stocksSurgical & Medical Instruments Industry13th out of 100 stocks 3.5 Analyst's Opinion Consensus RatingApyx Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageApyx Medical has received no research coverage in the past 90 days.Read more about Apyx Medical's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.15% of the float of Apyx Medical has been sold short.Short Interest Ratio / Days to CoverApyx Medical has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Apyx Medical has recently decreased by 20.63%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldApyx Medical does not currently pay a dividend.Dividend GrowthApyx Medical does not have a long track record of dividend growth. Previous Next 4.2 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreApyx Medical has received a 60.75% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Electrosurgical devices" product. See details.Environmental SustainabilityThe Environmental Impact score for Apyx Medical is -1.07. Previous Next 3.6 News and Social Media Coverage News SentimentApyx Medical has a news sentiment score of 1.51. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.88 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Apyx Medical this week, compared to 1 article on an average week.Search Interest3 people have searched for APYX on MarketBeat in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Apyx Medical insiders have not sold or bought any company stock.Percentage Held by Insiders13.10% of the stock of Apyx Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions55.33% of the stock of Apyx Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Apyx Medical's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Apyx Medical are expected to grow in the coming year, from ($0.75) to ($0.60) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Apyx Medical is -2.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Apyx Medical is -2.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioApyx Medical has a P/B Ratio of 1.87. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Apyx Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad InvestorPlaceJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market…Click here for the details About Apyx Medical Stock (NASDAQ:APYX)Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.Read More APYX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart APYX Stock News HeadlinesMay 17, 2024 | markets.businessinsider.comJMP Securities Reaffirms Their Hold Rating on Orthofix (OFIX)May 13, 2024 | finance.yahoo.comApyx Medical Corporation (NASDAQ:APYX) Q1 2024 Earnings Call TranscriptMay 12, 2024 | finance.yahoo.comAnalysts Have Been Trimming Their Apyx Medical Corporation (NASDAQ:APYX) Price Target After Its Latest ReportMay 11, 2024 | finance.yahoo.comApyx Medical First Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsMay 9, 2024 | msn.comAPYX Stock Earnings: Apyx Medical Misses EPS, Beats Revenue for Q1 2024May 9, 2024 | finance.yahoo.comApyx Medical Corporation Announces Board Leadership TransitionMay 9, 2024 | finance.yahoo.comApyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial OutlookApril 25, 2024 | finance.yahoo.comApyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024April 22, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Lifestance Health Group (LFST), LifeMD (LFMD)April 21, 2024 | finance.yahoo.comApyx Medical Corporation (APYX)April 17, 2024 | finance.yahoo.comOcean Drive Plastic Surgery Founder Dr. Alan Durkin Appointed VIO Med Spa Chief Medical OfficerApril 11, 2024 | finance.yahoo.comApyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ SummitApril 11, 2024 | businesswire.comApyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users' SummitMarch 26, 2024 | finance.yahoo.comDowngrade: Here's How Analysts See Apyx Medical Corporation (NASDAQ:APYX) Performing In The Near TermMarch 23, 2024 | seekingalpha.comApyx Medical Corporation (APYX) Q4 2023 Earnings Call TranscriptMarch 23, 2024 | finance.yahoo.comApyx Medical Corporation (NASDAQ:APYX) Just Reported And Analysts Have Been Cutting Their EstimatesMarch 22, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Apyx Medical (APYX) and OKYO Pharma Limited Sponsored ADR (OKYO)March 22, 2024 | finance.yahoo.comApyx Medical Corporation (NASDAQ:APYX) Q4 2023 Earnings Call TranscriptMarch 22, 2024 | finance.yahoo.comFurther weakness as Apyx Medical (NASDAQ:APYX) drops 22% this week, taking three-year losses to 87%March 22, 2024 | markets.businessinsider.comApyx Medical (APYX) Receives a Hold from JMP SecuritiesMarch 21, 2024 | finance.yahoo.comQ4 2023 Apyx Medical Corp Earnings CallMarch 21, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: OmniAb (OABI) and Apyx Medical (APYX)March 21, 2024 | investorplace.comAPYX Stock Earnings: Apyx Medical Misses EPS, Misses Revenue for Q4 2023March 21, 2024 | msn.comApyx Medical reports mixed Q4 results; initiates FY24 outlookMarch 21, 2024 | washingtonpost.comApyx: Q4 Earnings SnapshotSee More Headlines Receive APYX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Apyx Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2024Today6/13/2024Next Earnings (Estimated)8/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:APYX CUSIPN/A CIK719135 Webwww.apyxmedical.com Phone(727) 384-2323Fax800-323-1640Employees252Year FoundedN/APrice Target and Rating Average Stock Price Target$6.17 High Stock Price Target$9.00 Low Stock Price Target$4.50 Potential Upside/Downside+322.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.66) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-18,710,000.00 Net Margins-45.20% Pretax Margin-45.63% Return on Equity-76.16% Return on Assets-32.98% Debt Debt-to-Equity Ratio1.64 Current Ratio5.87 Quick Ratio4.94 Sales & Book Value Annual Sales$52.35 million Price / Sales0.97 Cash FlowN/A Price / Cash FlowN/A Book Value$0.78 per share Price / Book1.87Miscellaneous Outstanding Shares34,640,000Free Float30,106,000Market Cap$50.57 million OptionableOptionable Beta1.25 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.Get This Free Report Key ExecutivesMr. Charles D. Goodwin II (Age 57)President, CEO & Director Comp: $813.13kMr. Matthew C. Hill CPA (Age 55)CFO, Treasurer & Secretary Comp: $445.95kMr. Moshe Citronowicz (Age 71)Senior Vice President Comp: $405.47kMr. Todd Hornsby (Age 47)Executive Vice President Comp: $561.77kKey CompetitorsPolyPidNASDAQ:PYPDCVRxNASDAQ:CVRXProfound MedicalNASDAQ:PROFNeuroPaceNASDAQ:NPCEDelcath SystemsNASDAQ:DCTHView All CompetitorsInsiders & InstitutionsPerkins Capital Management Inc.Bought 15,000 shares on 5/10/2024Ownership: 0.660%Kingsview Wealth Management LLCBought 18,943 shares on 5/9/2024Ownership: 0.090%Commonwealth Equity Services LLCBought 497,080 shares on 4/30/2024Ownership: 1.435%Silverberg Bernstein Capital Management LLCBought 7,507 shares on 4/11/2024Ownership: 1.794%Matthew C HillBought 2,500 shares on 12/12/2023Total: $5,475.00 ($2.19/share)View All Insider TransactionsView All Institutional Transactions APYX Stock Analysis - Frequently Asked Questions Should I buy or sell Apyx Medical stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Apyx Medical in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" APYX shares. View APYX analyst ratings or view top-rated stocks. What is Apyx Medical's stock price target for 2024? 2 analysts have issued 12-month price targets for Apyx Medical's stock. Their APYX share price targets range from $4.50 to $9.00. On average, they expect the company's stock price to reach $6.17 in the next twelve months. This suggests a possible upside of 322.4% from the stock's current price. View analysts price targets for APYX or view top-rated stocks among Wall Street analysts. How have APYX shares performed in 2024? Apyx Medical's stock was trading at $2.62 at the beginning of 2024. Since then, APYX stock has decreased by 44.3% and is now trading at $1.46. View the best growth stocks for 2024 here. Are investors shorting Apyx Medical? Apyx Medical saw a decrease in short interest during the month of May. As of May 31st, there was short interest totaling 327,500 shares, a decrease of 20.6% from the May 15th total of 412,600 shares. Based on an average daily trading volume, of 140,800 shares, the short-interest ratio is currently 2.3 days. Approximately 1.2% of the company's shares are sold short. View Apyx Medical's Short Interest. When is Apyx Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 8th 2024. View our APYX earnings forecast. How were Apyx Medical's earnings last quarter? Apyx Medical Co. (NASDAQ:APYX) announced its earnings results on Thursday, May, 9th. The company reported ($0.22) EPS for the quarter, missing analysts' consensus estimates of ($0.18) by $0.04. The company earned $10.24 million during the quarter, compared to analysts' expectations of $9.64 million. Apyx Medical had a negative trailing twelve-month return on equity of 76.16% and a negative net margin of 45.20%. During the same quarter last year, the business posted ($0.10) earnings per share. What guidance has Apyx Medical issued on next quarter's earnings? Apyx Medical issued an update on its FY 2024 earnings guidance on Friday, May, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $49.7 million-$52.9 million, compared to the consensus revenue estimate of $49.9 million. What other stocks do shareholders of Apyx Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Apyx Medical investors own include Main Street Capital (MAIN), Johnson & Johnson (JNJ), ONEOK (OKE), Occidental Petroleum (OXY), Procter & Gamble (PG), STORE Capital (STOR), Wells Fargo & Company (WFC), Boeing (BA), Bank of America (BAC) and Delta Air Lines (DAL). Who are Apyx Medical's major shareholders? Apyx Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include Silverberg Bernstein Capital Management LLC (1.79%), Commonwealth Equity Services LLC (1.43%), Perkins Capital Management Inc. (0.66%), Kingsview Wealth Management LLC (0.09%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Charles D Goodwin II, Matthew C Hill and Todd Hornsby. View institutional ownership trends. How do I buy shares of Apyx Medical? Shares of APYX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:APYX) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredLike Investing in Big Tech in the Early 2000s?More than a decade after the first Bitcoin was mined, people are finally realizing something very important......Manward Press | SponsoredAn utter travestyThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredGold Prices Surge and This $0.32 Stock Is Reaping The RewardsGold prices are on the rise. This surge in gold prices is great news for gold mining stocks. Especially ...Market JAR | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | SponsoredMoonshot Coins for the Current Crypto RunAre you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealt...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apyx Medical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apyx Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.